ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,264,000 | -51.7% | 23,657 | +2.0% | 0.33% | -52.3% |
| Q4 2015 | $2,619,000 | -0.9% | 23,182 | +3.2% | 0.70% | -0.4% |
| Q3 2015 | $2,644,000 | -71.0% | 22,459 | -80.9% | 0.70% | -66.7% |
| Q2 2015 | $9,104,000 | +33.5% | 117,575 | -0.3% | 2.10% | +35.4% |
| Q1 2015 | $6,819,000 | +7.6% | 117,875 | -40.0% | 1.55% | +17.3% |
| Q4 2014 | $6,339,000 | -44.3% | 196,557 | -57.8% | 1.32% | -35.4% |
| Q3 2014 | $11,385,000 | +18.2% | 465,252 | -14.3% | 2.04% | +31.4% |
| Q2 2014 | $9,630,000 | -8.6% | 543,162 | +3.2% | 1.56% | -9.8% |
| Q1 2014 | $10,534,000 | +21.1% | 526,459 | +1.5% | 1.72% | +20.2% |
| Q4 2013 | $8,700,000 | +57.5% | 518,466 | -0.3% | 1.44% | +35.5% |
| Q3 2013 | $5,523,000 | +91.9% | 520,091 | +1.0% | 1.06% | +67.3% |
| Q2 2013 | $2,878,000 | – | 514,891 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |